Recipient HLA-DR3, tumour necrosis factor-α promoter allele-2 (tumour necrosis factor-2) and cytomegalovirus infection are inter-related risk factors for chronic rejection of liver grafts
- 31 May 2001
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 34 (5), 711-715
- https://doi.org/10.1016/s0168-8278(00)00101-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejectionHepatology, 2000
- Cytokine gene polymorphisms predict acute graft rejection following renal transplantationKidney International, 1999
- CYTOKINE GENE POLYMORPHISM AND HEART TRANSPLANT REJECTION1Transplantation, 1997
- Sex mismatch as a risk factor for chronic rejection of liver allograftsThe Lancet, 1995
- Functional Analysis of a New Polymorphism in the Human TNF α Gene PromoterScandinavian Journal of Immunology, 1995
- A polymorphic variation in a putative regulation box of the TNFA promoter regionImmunogenetics, 1994
- THE INFLUENCE OF HLA MATCHING ON CYTOMEGALOVIRUS HEPATITIS AND CHRONIC REJECTION AFTER LIVER TRANSPLANTATIONTransplantation, 1993
- PRODUCTION OF CYTOKINES (TNF-ALPHA, IL-1-BETA) AND ENDOTHELIAL CELL ACTIVATION IN HUMAN LIVER ALLOGRAFT REJECTION1Transplantation, 1993
- An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles.The Journal of Experimental Medicine, 1993
- I. EVIDENCE THAT ELEVATED LEVELS OF TUMOR NECROSIS FACTOR-ALPHA PREDICT REJECTION FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1990